Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Thrombin-inhibitory anticoagulants prepared by Merck scientists

June 28, 1999

Another series of factor Xa inhibitors patented by AxyS

June 25, 1999

AxyS describes further research on factor Xa inhibitors

June 23, 1999

Xenova refocuses research at MetaXen subsidiary

June 22, 1999

Inhibitors of serine proteases in the pipeline at 3-D

June 22, 1999

Schering-Plough scientists prepare thrombin receptor antagonists

June 22, 1999

AxyS claims heterocyclic factor Xa inhibitors

June 22, 1999

Retavase now available in Canada for emergency treatment of heart attacks

June 22, 1999

Carbohydrate anticoagulants with low sulfate content result from European collaboration

June 21, 1999

AHP launches ReFacto hemophilia A treatment in the U.K.

June 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...